• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Currenc Group Inc (OP: CURR )

    N/A UNCHANGED
    Last Price Updated: 3:04 PM EDT, Aug 8, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Press Releases about Currenc Group Inc

    < Previous 1 2 Next >
    Avenir Wellness Solutions Reports Third Quarter 2023 Results
    Via ACCESSWIRE
    Avenir Wellness Solutions Announces New Ticker Symbol As Final Part of Exciting New Brand Identity
    Via ACCESSWIRE
    Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year Over Year Revenue Increases and Continued High Gross Margins
    Via ACCESSWIRE
    Avenir Wellness Solutions Update to Stockholders
    Via ACCESSWIRE
    Wide Marketing and Shipments Commenced for New Patent Pending DNA Complex Skin Care Used by Top Movie and TV Star Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
    Via Get News
    Topics Intellectual Property
    Exposures Intellectual Property
    Avenir Wellness Solutions (OTCQB:CURR) to Present at the Planet MicroCap Showcase - Live Webcast Available
    Via ACCESSWIRE
    Avenir Wellness Letter to Stockholders
    Via ACCESSWIRE
    Avenir's Sera Labs Launches Patent Pending DNA Complex with Advanced Peptides and Compounds - Providing Instant and Long-Lasting Results With Daily Use
    Via ACCESSWIRE
    CURE Pharmaceutical Unveils Exciting New Brand Identity with Name Change to Avenir Wellness Solutions, Inc.
    Via ACCESSWIRE
    CURE Pharmaceutical Letter to Shareholders
    Via ACCESSWIRE
    Most Powerful Anti-Aging Product Lines with Patent Pending DNA Complex; Endorsed by Oscars Night 2023 Presenter Nicole Kidman: Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
    Via Get News
    Topics Intellectual Property
    Exposures Intellectual Property
    Avenir Wellness Solutions, Inc. Gains High Profile Exposure on theSkimm Social Media Platform With 7 Million Followers and Launches New Website in Support of Corporate Rebranding
    Via ACCESSWIRE
    Nicole Kidman Endorsed Wellness and Beauty Products; On-Track for Accelerated Sales Growth with Company Rebranded as Avenir Wellness Solutions, Inc. (Stock Symbol: CURR)
    Via Get News
    Topics Intellectual Property
    Exposures Intellectual Property
    Avenir Wellness Solutions to Launch Wall Street-focused Informational Series with Producer New to The Street
    Via ACCESSWIRE
    CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
    Via ACCESSWIRE
    Anti-Aging Wellness Products; Q3 Revenues Surge; $20 Million non-dilutive IP Asset Sale: Cure Pharmaceutical Inc. (Stock Symbol: CURR)
    Via Get News
    Topics Intellectual Property
    Exposures Intellectual Property
    $20 Million Cash Gain from Partial IP Asset Sale and Strong Financial Growth with Projected Acceleration: CURE Pharmaceutical: (Stock Symbol: CURR)
    Via Get News
    CURE Pharmaceuticals Holding Corp. (CURR) Featured in Virtual Coverage of NIBA’s 148th Investment Conference
    Via Investor Brand Network
    Topics Intellectual Property
    Exposures Intellectual Property
    $20 Million sale of IP Platform Technology; Health and Beauty Lines Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
    Via Get News
    Topics Intellectual Property
    Exposures Intellectual Property
    Marketing Partnerships for Advanced Health and Beauty Lines; Products Available at Walmart, Bed Bath & Beyond, CVS & Target.com: CURE Pharmaceutical (Stock Symbol: CURR)
    Via Get News
    Topics Intellectual Property
    Exposures Intellectual Property
    Keynotes, Educational Panels and 88 Companies to Present at the Planet MicroCap Showcase on May 3-5, 2022 at Bally's Hotel & Casino in Las Vegas, NV
    LOS ANGELES, CA / ACCESSWIRE / April 27, 2022 / SNN Network presents the Planet MicroCap Showcase taking place on May 3-5, 2022, where 88 MicroCap public and private companies will be presenting at... 
    From Stock News Now
    Via AccessWire
    Patented Oral Thin Film Drug Delivery Advancements with Applications on Key Health & Beauty Products; Partnered with Super Star Nicole Kidman: CURE Pharmaceutical (OTCQB: CURR)
    Via Get News
    CURE Pharmaceutical Reports Second Quarter 2021 Revenue Rose Nearly 700% Driven by Sales from Sera Labs Product Lines
    From CURE Pharmaceutical Holding Corp.
    Via Business Wire
    CURE Pharmaceutical to Present at H.C. Wainwright 2021 Psychedelics in Psychiatry and Beyond Virtual Conference
    From CURE Pharmaceutical Holding Corp.
    Via Business Wire
    CURE Pharmaceutical Signs Agreement to Develop CBD and THC Oral Thin Films and Conduct Clinical Studies Targeting Veteran Health
    From CURE Pharmaceutical Holding Corp.
    Via Business Wire
    Keynotes, Educational Panels and 60 Companies to Present at the SNN Network Summer Virtual Event on August 17-19, 2021
    LOS ANGELES, CA / ACCESSWIRE / August 16, 2021 / The SNN Network Summer Virtual Event will take place on August 17-19, 2021, where 60 SmallCap, MicroCap and NanoCap public and private companies will be... 
    From Stock News Now
    Via AccessWire
    Topics Cannabis
    Exposures Cannabis
    Nicole Kidman and Sera Labs Inc., a CURE Pharmaceutical Company, Launch Seratopical Revolution and New Ad Campaign
    From Sera Labs
    Via Business Wire
    CURE Pharmaceutical Schedules Investor Webcast for Thursday, May 27, 2021
    From CURE Pharmaceutical Holding Corp.
    Via Business Wire
    CURE Pharma (Stock Symbol: CURR) Q1 Revenue Quadruples to $1.5 million; Marketing Strength Grows with ISO Certification
    (Stock Symbol: CURR), Sees Q1 Revenues Jump Fourfold; Marketing Strength Grows with Recent ISO Certification and Expansion of New Biopharma Product Lines 
    Via EIN Presswire
    CURE Pharmaceutical First Quarter Revenue Quadruples to $1.5 million; Company Expands Clinical Pipeline to Include Psychedelics
    From CURE Pharmaceutical Holding Corp.
    Via Business Wire
    < Previous 1 2 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.